A randomized trial of coenzyme Q10 in patients with confirmed statin myopathy.

Atherosclerosis

Division of Cardiology, Henry Low Heart Center, Hartford Hospital, Hartford, CT, USA; University of Connecticut School of Medicine, Farmington, CT, USA.

Published: February 2015

Background: Coenzyme Q10 (CoQ10) supplementation is the most popular therapy for statin myalgia among both physicians and patients despite limited and conflicting evidence of its efficacy.

Objective: This study examined the effect of coenzyme Q10 (CoQ10) supplementation on simvastatin-associated muscle pain, muscle strength and aerobic performance in patients with confirmed statin myalgia.

Methods: Statin myalgia was confirmed in 120 patients with prior symptoms of statin myalgia using an 8-week randomized, double-blind crossover trial of simvastatin 20 mg/d and placebo. Forty-one subjects developed muscle pain with simvastatin but not with placebo and were randomized to simvastatin 20 mg/d combined with CoQ10 (600 mg/d ubiquinol) or placebo for 8 weeks. Muscle pain (Brief Pain Inventory [BPI]), time to pain onset, arm and leg muscle strength, and maximal oxygen uptake (VO2max) were measured before and after each treatment.

Results: Serum CoQ10 increased from 1.3 ± 0.4 to 5.2 ± 2.3 mcg/mL with simvastatin and CoQ10, but did not increase with simvastatin and placebo (1.3 ± 0.3 to 0.8 ± 0.2) (p < 0.05). BPI pain severity and interference scores increased with simvastatin therapy (both p < 0.01), irrespective of CoQ10 assignment (p = 0.53 and 0.56). There were no changes in muscle strength or VO2max with simvastatin with or without CoQ10 (all p > 0.10). Marginally more subjects reported pain with CoQ10 (14 of 20 vs 7 of 18; p = 0.05). There was no difference in time to pain onset in the CoQ10 (3.0 ± 2.0 weeks) vs. placebo (2.4 ± 2.1 wks) groups (p = 0.55). A similar lack of CoQ10 effect was observed in 24 subjects who were then crossed over to the alternative treatment.

Conclusions: Only 36% of patients complaining of statin myalgia develop symptoms during a randomized, double-blind crossover of statin vs placebo. CoQ10 supplementation does not reduce muscle pain in patients with statin myalgia. Trial RegistrationNCT01140308; www.clinicaltrials.gov.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4298455PMC
http://dx.doi.org/10.1016/j.atherosclerosis.2014.12.016DOI Listing

Publication Analysis

Top Keywords

coenzyme q10
12
statin myalgia
12
muscle pain
12
patients confirmed
8
confirmed statin
8
q10 coq10
8
coq10 supplementation
8
muscle strength
8
simvastatin 20 mg/d
8
simvastatin placebo
8

Similar Publications

Background: Obesity, a rising global health issue, is linked to numerous disorders, including cognitive impairment.

Objectives: This study investigates the effects of coenzyme Q10 (Co-Q10) on cognitive performance, antioxidant defense, cholinergic activity, and hippocampal neuron damage in rats rendered obese by monosodium glutamate (MSG) exposure.

Methods: Forty-eight neonatal male Wistar rats were randomly assigned to one of four groups: Control, MSG, MSG + Q10-10, and MSG + Q10-20.

View Article and Find Full Text PDF

[Research progress on the role and mechanism of ferroptosis in heart diseases].

Sheng Li Xue Bao

February 2025

Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Capital Medical University, Beijing 100069, China.

Cardiovascular disease remains the leading cause of death in China, with its morbidity and mortality continue to rise. Ferroptosis, a unique form of iron-dependent cell death, plays a major role in many heart diseases. The classical mechanisms of ferroptosis include iron metabolism disorder, oxidative antioxidant imbalance and lipid peroxidation.

View Article and Find Full Text PDF

sp. nov. and sp. nov., two novel species isolated from rhizosphere soil and a root of halophyte .

Int J Syst Evol Microbiol

March 2025

Ministry of Education Key Laboratory of Ecology and Resource Use of the Mongolian Plateau, School of Ecology and Environment, Inner Mongolia University, Hohhot, 010020, PR China.

Two bacteria, designated strain M1R2S20 and RD2P27, were isolated from rhizosphere soil and a root of in Baotou, Inner Mongolia, China. Phylogenetic analyses based on the 16S rRNA gene sequences revealed that strains M1R2S20 and RD2P27 were tightly clustered and both shared the highest 16S rRNA gene similarities (98.6 and 98.

View Article and Find Full Text PDF

A novel bacterial strain, designated Dechloromonas aquae ZY10, was isolated from the aquaculture water of grass carp. The colonies exhibited diameters ranging from approximately 1 to 3 mm and were characterized by a creamy-white coloration, circular shape, smooth texture, translucency, and a convex profile. The cells were facultatively anaerobic and motile, utilizing a single polar flagellum for movement.

View Article and Find Full Text PDF

Two cases of neonatal hyperglycemia caused by a homozygous COQ9 stop-gain variant.

J Diabetes Investig

March 2025

Department of Clinical and Biomedical Sciences, Faculty of Health and Life Sciences, University of Exeter, Exeter, UK.

Neonatal diabetes mellitus (NDM) is a monogenic condition diagnosed <6 months of age with >40 genetic causes. International guidelines recommend referral for genetic testing immediately after diagnosis since the genetic result guides clinical management. We used next-generation sequencing to identify a homozygous pathogenic variant, p.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!